Macustat study highlights Digital Health advancements with evidence-based remote monitoring tools in Ophthalmic Press
The study is one of the first clinical trials to validate the clinical utility of real-world remote physiologic monitoring using an on-demand vision-as-a-service (VaaS) extension to the specialty retina clinic to enable remote monitoring of patients with chronic diseases such as AMD, diabetic retinopathy, and other retinal conditions. Macustat is a part of a suite of cloud-based VaaS digital health applications which includes remote monitoring tests for glaucoma, AMD, DME, and other chronic conditions.